Virtual nature walks for depression in progressive multiple sclerosis
Official title: Bringing the Outdoors In: Virtual Nature Walks for Depression in Multiple Sclerosis (MS) Patients
Run by University of Michigan · NCT07392879 · Data updated 2026-11-12
This project tests whether immersive at-home virtual-reality nature walks using the Apple Vision Pro, added to usual care, can reduce depressive symptoms in people with progressive MS.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | University of Michigan Academic / other |
| Locations | 1 site (Ann Arbor, Michigan) |
| Status | Recruiting |
| Started | December 15, 2025 |
| Main results expected | April 2027 |
| Study ends | April 2027 |
| Registry record updated | February 12, 2026 |
| Trial ID | NCT07392879 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with neurologist-confirmed primary or secondary progressive MS who have PROMIS Depression T-scores >55, can consent and use VR at home, and (for some groups) are receiving antidepressant medication or psychotherapy are ideal candidates.
✕Probably not a fit
People with severe cognitive or visual impairments, marked motion sickness or claustrophobia, active suicidal ideation or other uncontrolled psychiatric conditions, or those enrolled in other depression trials are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study delivers immersive VR nature experiences on the Apple Vision Pro to people with progressive MS and elevated depressive symptoms, comparing VR plus usual care, VR alone, and usual care alone. Participants complete at-home sessions while researchers measure feasibility, acceptability, and changes in depression, stress, anxiety, sleep, insomnia, and fatigue using PROMIS and other patient-reported measures. The trial emphasizes remote deployment and usability testing of a high-resolution consumer headset to overcome mobility barriers common in progressive MS. Outcomes will compare symptom change and adherence across groups to see if combining VR with current therapies provides greater benefit.
Why it matters
Potential benefit: If successful, the intervention could offer an accessible at-home way to reduce depression, stress, and fatigue and improve sleep for people with progressive MS.
How similar studies have gone: Prior VR nature and immersive relaxation studies have shown modest mood and stress improvements in general and some neurological populations, but applying high-resolution headsets like the Apple Vision Pro specifically in progressive MS is largely novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Confirmed diagnosis of progressive Multiple Sclerosis (MS, primary or secondary) by a neurologist or an MS center * Patient-Reported Outcomes Measurement Information System (PROMIS) Depression T-scores \>55 at baseline * Ability to provide informed consent and participate in VR sessions at home * For Some Participants (Groups 1 and 2) currently receiving antidepressant or psychotherapy treatments (Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), or psychotherapy) for the management of depression Exclusion Criteria: * Severe cognitive impairments or visual deficits that may interfere with VR use, including contraindications like agoraphobia, claustrophobia, or motion sickness * Current participation in other clinical trials targeting depression * Severe psychiatric conditions that require hospitalization, or suicidal ideation, passive or active, psychosis, or active substance and alcohol abuse (score greater than 1 on CAGE (Cut down, Annoyed, Guilty, Eye-opener) Adapted to Include Drugs (CAGE-AID)) * Another neurological or autoimmune disease per protocol * Participants that require vision correction, unless that vision correction is mild (± 1), or the participant has prescription contact lenses.
Where it's running
-
University of Michigan
Ann Arbor, Michigan, United States Recruiting
Study contacts
- Principal investigator: Hala Darwish, PhD — University of Michigan
- Study coordinator: Zee Petrie
- Email: petrieli@umich.edu
- Phone: 734- 764- 5249
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Smartphone-supported single-session psychotherapy for postpartum depression
A single online therapy session plus four weeks of app-based support is being tested to see if it reduces depressive symptoms in postpartum women compared with a waitlist.
-
Mindful Smartphone Use: A Mindfulness-Based Program for Teens with Sleep and Mood Challenges
This study tests Mindwire, a mindfulness-based program, to see if it helps teens with problematic phone use who also have depression or anxiety.
-
Tele-based wellbeing centres for women's mental health in Bangladesh
A randomized trial tests whether tele-counselling for depression and anxiety in Bangladeshi women is as effective as in-person counselling.
-
Remote monitoring for adults with depression using ThIA Suivi
This study tests whether adding the ThIA Suivi remote monitoring tool to usual psychiatric care helps adults with depression feel more improved after 3 months compared with standard care alone.
-
HBOT to see if it helps cognition and well‑being in first responders with prior brain injury
This study tests whether 40 hyperbaric oxygen therapy sessions can improve thinking skills and post-concussion symptoms in current or former first responders with a history of brain injury.
-
Focused ultrasound for mood and anxiety disorders
This study tests whether repeated low-intensity focused ultrasound using the ATTN201 device can help people with subsyndromal to moderate depression, anxiety, or OCD.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.